From: Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma
Parameter | Risk ratio | 95% Confidence interval | p-Value |
---|---|---|---|
P-Smad2 expression | 0.627 | 0.347-1.133 | 0.122 |
Low vs. high | |||
Morphologic feature | 2.325 | 1.221-4.388 | 0.010 |
Type 1, 2, and 3 vs. type 4 | |||
Differentiation | 2.807 | 1.251-6.298 | 0.012 |
Intestinal-type vs. Diffuse-type | |||
Lymph node metastasis (Japanese classification) | 1.387 | 0.689-2.794 | 0.360 |
N0 and N1 vs. N2 and N3 | |||
Peritoneal dissemination | 1.097 | 0.549-2.193 | 0.793 |
Negative vs. positive | |||
Lymphatic invasion | 1.394 | 0.805-2.413 | 0.235 |
Ly0 and ly1 vs. ly2 and ly3 | |||
Clinical Stage | 4.382 | 1.924-9.978 | < 0.001 |
I, II, and III vs. IV |